HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.

AbstractBACKGROUND:
Nordihydroguaiaretic acid (NDGA) is an inhibitor of the IGF-1 receptor (IGF-1R) in breast and other cancers, and concomitantly inhibits tumor growth both in cultured cells and animals. The current study evaluates the effect of NDGA on the androgen-stimulated growth of human prostate cancer cells.
METHODS:
LAPC-4 prostate cancer cells in tissue culture were androgen starved for 3 days, 1 nM dihydrotestosterone (DHT) and other androgens were then added for up to 7 days, and cell proliferation measured. IGF-1R protein expression was measured by Western blot, and IGF-1R mRNA expression by quantitative PCR. IGF-1R receptor kinase activation was measured by ELISA.
RESULTS:
After 7 days, LAPC-4 growth was doubled by 1 nM DHT. NDGA had a rapid effect to inhibit IGF-1R autophosphorylation induced by IGF-1. DHT increased the expression of IGF-1R protein and mRNA levels. Maximal IGF-1R protein levels were observed 3 days after the addition of androgen. In addition, NDGA, at 10 microM or less, inhibited DHT-induced proliferation in both cells grown in plates and cells grown in soft agar. Androgen receptor (AR) studies by FRET revealed that NDGA had no conformational effects on the AR in response to ligand.
CONCLUSIONS:
NDGA blocks the DHT-induced growth of LAPC-4 prostate cancer cells by several mechanisms including rapid inhibition of the IGF-1R kinase, and a dose-dependent inhibition of androgen stimulation of IGF-1R expression. Clinical studies of this agent will determine its efficacy in the setting of androgen-dependent prostate cancer.
AuthorsCharles J Ryan, Marianna Zavodovskaya, Jack F Youngren, Michael Campbell, Marc Diamond, Jeremy Jones, Laura Shiry, Geoffrey Allan, Betty A Maddux, Ira D Goldfine
JournalThe Prostate (Prostate) Vol. 68 Issue 11 Pg. 1232-40 (Aug 01 2008) ISSN: 0270-4137 [Print] United States
PMID18491370 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2008 Wiley-Liss, Inc.
Chemical References
  • Antioxidants
  • RNA, Messenger
  • Receptors, Androgen
  • Dihydrotestosterone
  • Masoprocol
  • Receptor, IGF Type 1
Topics
  • Antioxidants (pharmacology)
  • Cell Division (drug effects, physiology)
  • Cell Line, Tumor
  • Dihydrotestosterone (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Male
  • Masoprocol (pharmacology)
  • Phosphorylation (drug effects)
  • Prostatic Neoplasms (drug therapy, pathology, physiopathology)
  • Protein Conformation
  • RNA, Messenger (metabolism)
  • Receptor, IGF Type 1 (genetics, metabolism)
  • Receptors, Androgen (chemistry, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: